ZA200801724B - An improved monolithic drug delivery system - Google Patents

An improved monolithic drug delivery system

Info

Publication number
ZA200801724B
ZA200801724B ZA200801724A ZA200801724A ZA200801724B ZA 200801724 B ZA200801724 B ZA 200801724B ZA 200801724 A ZA200801724 A ZA 200801724A ZA 200801724 A ZA200801724 A ZA 200801724A ZA 200801724 B ZA200801724 B ZA 200801724B
Authority
ZA
South Africa
Prior art keywords
delivery system
drug delivery
monolithic drug
improved monolithic
improved
Prior art date
Application number
ZA200801724A
Other languages
English (en)
Inventor
Sibongile R Sibambo
Pillay Viness
Choonara Yahya Essop
Original Assignee
Univ Witwatersrand Jhb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Witwatersrand Jhb filed Critical Univ Witwatersrand Jhb
Priority to ZA200801724A priority Critical patent/ZA200801724B/xx
Publication of ZA200801724B publication Critical patent/ZA200801724B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200801724A 2007-02-23 2008-02-22 An improved monolithic drug delivery system ZA200801724B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200801724A ZA200801724B (en) 2007-02-23 2008-02-22 An improved monolithic drug delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200609747 2007-02-23
ZA200801724A ZA200801724B (en) 2007-02-23 2008-02-22 An improved monolithic drug delivery system

Publications (1)

Publication Number Publication Date
ZA200801724B true ZA200801724B (en) 2009-07-29

Family

ID=41328434

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801724A ZA200801724B (en) 2007-02-23 2008-02-22 An improved monolithic drug delivery system

Country Status (5)

Country Link
US (1) US20100068169A1 (ja)
EP (1) EP2124902B1 (ja)
JP (1) JP5171847B2 (ja)
WO (1) WO2008102248A2 (ja)
ZA (1) ZA200801724B (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62209161A (ja) * 1986-03-11 1987-09-14 Taki Chem Co Ltd 多孔性基剤
US5912015A (en) * 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US5656297A (en) * 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US6531154B1 (en) * 1997-06-10 2003-03-11 Brown University Research Foundation Modulated release from biocompatible polymers
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
EP1356809A4 (en) * 2000-12-28 2008-05-14 Takeda Pharmaceutical SUSTAINED RELEASE PREPARATIONS
EP1613796B1 (en) * 2003-04-10 2017-03-22 Tufts University Concentrated aqueous silk fibroin solution and use thereof

Also Published As

Publication number Publication date
EP2124902B1 (en) 2015-08-26
WO2008102248A3 (en) 2009-10-22
US20100068169A1 (en) 2010-03-18
JP2011500507A (ja) 2011-01-06
WO2008102248A2 (en) 2008-08-28
EP2124902A2 (en) 2009-12-02
JP5171847B2 (ja) 2013-03-27

Similar Documents

Publication Publication Date Title
ZA201002014B (en) Drug delivery system
GB2442875B (en) Regulated drug delivery system
ZA201101737B (en) Progestin-containing drug delivery system
EP2178598A4 (en) IONTOPHORETIC DRUG DISTRIBUTION SYSTEM
EP1901796A4 (en) DRUG DELIVERY SYSTEM
EP2401012A4 (en) ACTIVE RELEASE SYSTEM
PL3395372T3 (pl) Układ do dostarczania leków na bazie glutationu
IL224505A (en) Device for administering drugs
IL198911A0 (en) Drug delivery
EP2299989A4 (en) STABILIZED TRANSDERMAL DRUG DISPENSING SYSTEM
IL242028A0 (en) A system for dispensing doses of medicine operated by means of a micro-pump
IL219001A0 (en) Drug delivery device
EP2213274A4 (en) DRUG DELIVERY SYSTEM, AND DRUG DELIVERY DEVICE
IL227899A0 (en) Mixing properties for a drug release system
GB0707928D0 (en) Delivery system
EP1858483A4 (en) SYSTEM FOR THE DELIVERY OF MULTIPLE MEDICAMENTS
EP2481399A4 (en) ACTIVE COMPOSITION SYSTEM WITH LONG-TERM EFFECT
IL212357A0 (en) Sustained drug delivery system
EP2023900A4 (en) DRUG DELIVERY SYSTEM WITH CONTROLLED DOSES
AP2011005687A0 (en) Sustained release drug delivery system.
ZA200903317B (en) Helically-shaped drug delivery system
EP2226083A4 (en) ACTIVE RELEASE SYSTEM
ZA201006517B (en) Estradiol-containing drug delivery system
GB0515363D0 (en) Drug delivery system
ZA200801724B (en) An improved monolithic drug delivery system